GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Aurobindo Pharma Ltd

Aurobindo Pharma declares 700% interim dividend for FY27

DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 04 Nov 2026, 08:16 PM IST  ·  BSE ID: 25cde224-f003-4806-b011-2b60e5de323c
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved paying shareholders Rs. 7.00 for every share they own, from its profits for the year.
🤖 AI Summary
  • Aurobindo Pharma approved a 700% interim dividend of Rs. 7.00 per equity share.
  • The dividend payment is for the financial year 2026-27.
  • November 11, 2026, is set as the record date for dividend entitlement.
  • Dividend payments are scheduled to be completed by November 20, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Interim Dividend Percentage
700%
Interim Dividend Per Equity Share
Rs. 7.00
Equity Share Capital Face Value
Re.1/-
Record Date
November 11, 2026
Dividend Payment Deadline
November 20, 2026
🏢 How This Affects the Company
💰
Financial Impact
The declaration of an interim dividend will result in a cash outflow from the company, reducing its cash reserves by the total dividend amount payable to shareholders.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders. Eligible shareholders will receive the dividend automatically.
👤
Who Is Affected
Shareholders whose names appear on the company's register of members on November 11, 2026, will receive the dividend payment.
🔍
Management Signal
The decision to pay an interim dividend indicates management's confidence in the company's profitability and its intention to reward shareholders.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Confirmation of dividend payment by November 20, 2026.
Next quarterly results announcement for FY27.
Any further corporate actions or disclosures from the company.
LOW RISK Dividend declaration is a standard financial action with no inherent new risks introduced by the filing.
💡 Investor Takeaway
Aurobindo Pharma's Board approved a 700% interim dividend of Rs. 7.00 per equity share for FY27. Record date is November 11, 2026; payment by November 20, 2026.
⚖️ Strengths & Concerns

✅ Positives

  • Company declared a substantial 700% interim dividend, indicating profitable operations for FY27.
❓ Frequently Asked Questions
What is Aurobindo Pharma's interim dividend per share for FY27?
Aurobindo Pharma declared an interim dividend of Rs. 7.00 per equity share for the financial year 2026-27.
What is the record date for Aurobindo Pharma's interim dividend?
The record date for determining entitlement to the interim dividend is November 11, 2026.
When will Aurobindo Pharma pay its interim dividend?
The interim dividend payment will be made on or before November 20, 2026.
What is the dividend percentage declared by Aurobindo Pharma?
Aurobindo Pharma has approved an interim dividend of 700% on its equity share capital.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.